Points for Consideration for dengue vaccine introduction: recommendations by the Dengue Vaccine Initiative

Points for Consideration for dengue vaccine introduction : recommendations by the Dengue Vaccine Initiative

Special Isssue: Dengue Vaccines
Dengue is a public health problem in the tropics and subtropics. There are several vaccine candidates in clinical development. However, there may be gaps in the new vaccine introduction after vaccine licensure before it becomes available in developing countries. In anticipation of the first dengue vaccine candidate to be licensed, Dengue Vaccine Initiative (DVI) and, its predecessor, Pediatric Dengue Vaccine Initiative (PDVI) have been working on points for consideration to accelerate evidence-based dengue vaccine introduction, once a vaccine becomes available. In this paper, we review the history of PDVI and its successor, the DVI, and elaborate on the points of consideration for dengue vaccine introduction.

Ingår i:Expert Review of Vaccines: Informa UK Limited15:4, s. 529-5381476-05841744-8395

Av författaren/redakt...: Lim, Jacqueline ...; Lee, Yong-Seok; Wilder-Smith, An ...; Thiry, Georges; Mahoney, Richard; Yoon, In-Kyu

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Hälsovetenskap; och Folkhälsovetensk ...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.